TS-062319 — The Need The urgent need to address lymphoproliferative disorders, including B cell malignancies such as acute lymphoblastic leukemia (ALL) and high-grade lymphomas, drives the demand for innovative and effective therapeutic approaches. These aggressive diseases, characterized by the uncontrolled p…